Pfizer move to join tax-driven deal-making raises red flags in U.S

(Reuters) - A wave of tax-driven overseas deal-making by U.S. companies gained momentum with drugmaker Pfizer Inc's announcement on Monday that it had made takeover bids for UK rival AstraZeneca Plc , fueling political concerns about tax "reflagging" strategies.

from Reuters: Business News http://ift.tt/1hLtUgP